FDAnews Books Library

 

Gain Access to All Books and Reports

Our Books Library gives you year-round unrestricted access to all our books and reports.

They can be accessed, searched, downloaded and read anywhere, anytime. Topics covered include inspections, auditing, validation, recalls, pharmacovigilance, biosimilars, adverse events, QSR Data, supply chain, financial disclosure requirements and much more. You’ll automatically receive every new book we publish — we'll send you notifications to alert you of each new book in the library.

LOGIN

BUY NOW Single-User 1-Year Unlimited Access $1,297

Also available: Take advantage of our multi-user and site licenses of the FDAnews Books Library so you’ll have the most-informed workforce! Contact Will Tuttle, Business Development Representative at wtuttle@fdanews.com or +1 612.216.2948 to receive a custom quote.

Search by keyword (title of book maybe) or simply scroll through the list of titles to find what you need.

If you have any questions or are having any problems please give us a call on 703.538.7600 or email customer service.

The Revised ICH E8: A Guide to New Clinical Trial Requirements

April 15, 2020
With ICH E8(R1) set to be adopted in June 2020, your planning, design and conduct of clinical trials will look different than they do today. This management report shows you how to leverage the revised guidelines’ quality-by-design approaches, expanded study designs and data source considerations.

The Road to a Pharmaceutical Quality System in the EU

April 15, 2020
Does your quality management system comply with EU standards? In this management report international quality management and auditing expert Stephanie Blum explains the EU’s PQS requirements — including ISO standards and ICH guidelines.

Clinical Trials Adverse Event Reporting Guide - 2020 Edition

March 9, 2020
The Clinical Trials Adverse Event Reporting Guide covers more than 20 guidances from the FDA, HHS and the ICH and includes the text of all regulations pertaining to reporting adverse events in clinical trials.

Managing Data and Documentation for FDA Inspections - 2019

February 5, 2020
Is your company’s data and documentation organized and ready for your next FDA inspection? This management report will help you get control of your data by using industry best practices and SOPs.

Design Change Analysis: Five Steps to Compliance

January 30, 2020
This management report explains the design change procedure required by the FDA, including five steps that most devicemakers don’t realize are necessary until an FDA inspection points out the gap in a company’s procedures and documents.
Using ISO 11607 to Develop Risk-Based Device Packaging

Using ISO 11607 to Develop Risk-Based Device Packaging

December 9, 2019
Using case studies and other frontline knowledge this report will show you how to leverage a risk-based packaging approach to prevent nasty audits and recalls ... without busting a hole in your compliance budget. With it, you'll get step-by-step guidance through the bewildering FDA packaging requirements, beginning with a discussion of how and why packaging is causing significant harm to devicemakers. You'll also learn why your packaging might be at risk - and what you must do to reduce field complaints, recalls or FDA enforcement actions.
Using Social Media in Clinical Trial Recruitment

Using Social Media in Clinical Trial Recruitment

December 9, 2019
Today, one in five sponsors uses social media to engage, recruit, and retain subjects for clinical trials. And why not? Clearly, social media is increasingly where your prospective study subjects are going to be found. This report is designed to help unsure clinical trial recruiters put aside their concerns and go ahead with social media recruiting of trial subjects. And if you're already using social media, it's an opportunity to hear how other organizations are overcoming challenges and employing social media for increasingly successful recruitment.
Using the MDSAP Model to Win International Device Approval

Using the MDSAP Model to Win International Device Approval

December 9, 2019
This management report explains what MDSAP auditors will focus on and teaches you how to build an internal audit program that will get your quality system in state-of-the-art shape for international inspections.
Winning Device EU Marketing Approval: Seven Steps to Writing Clinical Evaluation Reports

Winning Device EU Marketing Approval: Seven Steps to Writing Clinical Evaluation Reports

December 9, 2019
If you want to market your device in Europe, you need to provide clinical evidence that the product is safe and effective. But if your development phase didnt include clinical trials, how can you make that argument? This FDAnews Brief walks you through the process of developing and writing a CER with a 7-point model that ensures you cover all the bases and have the greatest chance of success.
Understanding the New EU Medical Device Regulations

Understanding the New EU Medical Device Regulations

December 9, 2019
The EU has just made sweeping changes to its medical device regulations (MDR) — replacing the three current guidance directives with two massive regulations binding manufacturers to a variety of new requirements. This management report directs you through the new MDR and in vitro diagnostic device regulations (IVDR) and explains the impact on the development, marketing and monitoring of your devices.
Top Trends in Drug and Device Advertising and Promotion: Enforcement Priorities for the FDA and FTC

Top Trends in Drug and Device Advertising and Promotion: Enforcement Priorities for the FDA and FTC

December 9, 2019
Drug and device advertising, marketing and promotion are edging into some brave new worlds. Its not OK for creative teams to operate unaware of FDA and FTC rules and attitudes. This report takes a deep dive into six areas regulators give the most attention.
Troubleshooting Your Quality System: A Guide to Five Devicemaker Quality Compliance Traps

Troubleshooting Your Quality System: A Guide to Five Devicemaker Quality Compliance Traps

December 9, 2019
Medical device manufacturers often dread the FDA inspector's arrival. But here's a shortcut to success you can master in an hour or so. There is a little-known secret: Five problem areas account for one-fourth of all Form 483 observations the FDA issues devicemakers in a given year. Master these and you've taken a giant step toward inspection success. And now, FDAnews has created a management report focusing on just those five areas.

Upcoming Events

Featured Products

Featured Stories

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More